SEC
Fundamental Analysis
2523 matches · 10756 cached companies
| Company | Fundamental | Momentum | Acceleration | Confidence | Revenue Growth | ROIC | FCF Growth | Op Margin Delta | Share Growth | Dividend Yield | Dividend Years | Payout Ratio | P/E | Signals |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IESCIES Holdings, Inc. | 90.1 | 58.1 | 59.3 | 95 | +30.1% | +54.2% | +53.87% | +13.57% | -0.08% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| POWLPOWELL INDUSTRIES INC | 86 | 58.1 | 74.8 | 100 | +7.76% | +54.9% | +177.82% | +24.98% | +0.22% | 0.12% | 14 | 7.12% | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| UIUbiquiti Inc. | 85.4 | 91 | 94.6 | 100 | +42.35% | +113% | +19.4% | +4.92% | +0.07% | 0.55% | 9 | 20.16% | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Strong operating leverage |
| RMDRESMED INC | 84.9 | 70.6 | 75.4 | 100 | +12.64% | +27.01% | +47.14% | +5.8% | -1.19% | 1.12% | 15 | 22.95% | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| RSMDFRESMED INC | 84.9 | 70.6 | 75.4 | 100 | +12.64% | +27.01% | +47.14% | +5.8% | -1.19% | 1.09% | 10 | 22.95% | n/a | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| MUMICRON TECHNOLOGY INC | 84.2 | 100 | 100 | 100 | +200.23% | +71.72% | +17,701.92% | +33.8% | +1.96% | 0.05% | 6 | 1.16% | 25.04x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| INTUINTUIT INC. | 84.1 | 100 | 100 | 100 | +62.75% | +31.9% | +177.5% | +19.01% | -2.47% | 1.71% | 16 | 18.61% | 11.05x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| AUPHAurinia Pharmaceuticals Inc. | 91 | 100 | 100 | 91 | +19.76% | +33.2% | n/a | +90.72% | -2.91% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| VRSKVerisk Analytics, Inc. | 86.1 | 63.7 | 63.7 | 95 | +14.73% | n/a | +49.54% | +7.93% | -5.11% | 1.19% | 8 | 26.88% | 23.44x | Gross margin expansion, Operating leverage, FCF growth, Net debt reduction, Share count reduction, Strong operating leverage |
| ONCBeOne Medicines Ltd. | 89.9 | 100 | 100 | 91 | +56.49% | +26.09% | n/a | +195.04% | +4.16% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction |
| NFLXNETFLIX INC | 85.5 | 63.8 | 63.8 | 95 | +20.62% | +38.03% | +40.74% | +14.76% | -2.48% | 0% | 0 | n/a | 19.9x | Gross margin expansion, Operating leverage, FCF growth, Net debt reduction, Share count reduction, Strong operating leverage |
| ELMDElectromed, Inc. | 81.4 | 63.7 | 77.6 | 100 | +19.77% | +24.85% | -20.2% | +10.47% | -3.41% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
| IVDNINNOVATIVE DESIGNS INC | 85 | 64.5 | 74.4 | 95 | +46.53% | +18.91% | n/a | +198.92% | n/a | 0% | 0 | n/a | n/a | Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage |
| CVSACovista Inc. | 81.1 | 87.1 | 87 | 100 | +25.31% | +15.97% | +159.4% | +15.22% | -9.42% | 0% | 0 | n/a | 18.13x | Gross margin expansion, Operating leverage, FCF growth, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ATEXAnterix Inc. | 88 | 100 | 100 | 91 | +9.94% | +43.39% | n/a | +4,744.45% | +4.49% | 0% | 0 | n/a | 22.88x | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction |
| RDDTReddit, Inc. | 86.6 | 100 | 100 | 91 | +101.83% | +160.37% | +241.87% | n/a | +0.37% | 0% | 0 | n/a | 42.15x | Gross margin expansion, Operating leverage, FCF growth, Net debt reduction1 warning |
| NEPHNEPHROS INC | 86.2 | 87.5 | 92.5 | 91 | +34.56% | +17.86% | n/a | +53.63% | +4.68% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| DOCSDoximity, Inc. | 86 | 48.2 | 62.6 | 91 | +38.01% | +23.12% | n/a | +1.05% | -5.47% | 0% | 0 | n/a | 26.53x | ROIC expansion, Net debt reduction, Share count reduction, High quality compounder |
| URBNURBAN OUTFITTERS INC | 85.4 | 65 | 75.3 | 91 | +17.8% | +28.84% | n/a | +5.37% | -7.28% | 0% | 0 | n/a | 11.36x | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| GWREGuidewire Software, Inc. | 78 | 100 | 100 | 100 | +46.37% | +23.1% | -21.2% | +32.2% | +1.63% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion2 warnings |
| PGNYProgyny, Inc. | 85.5 | 61.9 | 77.1 | 91 | +5.54% | +34.52% | n/a | +3.55% | -8.36% | 0% | 0 | n/a | 26.36x | Gross margin expansion, Operating leverage, ROIC expansion, Share count reduction, Strong operating leverage |
| RDVTRed Violet, Inc. | 89.5 | 83.2 | 89.9 | 87 | +22.24% | +25.37% | n/a | +18.5% | -0.19% | 0% | 1 | n/a | 70.58x | Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ABNBAirbnb, Inc. | 84.9 | 65.1 | 79.1 | 91 | +23.71% | +115.79% | n/a | +6.65% | -5.54% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Share count reduction, Strong operating leverage |
| ELTPELITE PHARMACEUTICALS INC /NV/ | 84.9 | 100 | 100 | 91 | +107.85% | +73.84% | n/a | +16.82% | +5.65% | 0% | 0 | n/a | n/a | Gross margin expansion, Operating leverage, ROIC expansion, Net debt reduction, Strong operating leverage1 warning |
| NAGENiagen Bioscience, Inc. | 84.4 | 61.7 | 37 | 91 | +25.17% | +117.43% | n/a | +40.37% | -0.87% | 0% | 0 | n/a | 14.88x | Gross margin expansion, Operating leverage, Net debt reduction, Share count reduction, Strong operating leverage2 warnings |
1-25 of 2523